More about
Difficult-To-Treat Migraine
News
September 05, 2024
2 min read
Save
Monoclonal antibody superior to placebo in reducing migraine frequency
In patients with difficult-to-treat migraine, IV infusion of a novel monoclonal antibody provided superior migraine frequency relief compared with placebo in as early as 4 weeks, data show.